Bionomics Limited (BNOX)
USD 0.25
(4.59%)
USD 0.25
(4.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 227 Million USD | -4.81% |
| 2023 | -11.8 Million USD | 48.01% |
| 2022 | -22.69 Million USD | -9.55% |
| 2021 | -20.71 Million USD | -493.44% |
| 2020 | 5.26 Million USD | 74.24% |
| 2019 | 3.02 Million USD | 215.51% |
| 2018 | -2.61 Million USD | 86.05% |
| 2017 | -18.75 Million USD | -3.63% |
| 2016 | -18.09 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -12.5 Million USD | 0.0% |
| 2024 Q1 | -8.65 Million USD | 26.61% |
| 2024 Q2 | -9.06 Million USD | -4.62% |
| 2023 Q3 | -11.95 Million USD | 41.61% |
| 2023 FY | -11.8 Million USD | 48.01% |
| 2023 Q4 | -11.8 Million USD | 1.33% |
| 2023 Q2 | -20.48 Million USD | -5.86% |
| 2023 Q1 | -19.34 Million USD | 14.76% |
| 2022 Q4 | -22.69 Million USD | 0.0% |
| 2022 FY | -22.69 Million USD | -9.55% |
| 2022 Q2 | -28.75 Million USD | 0.0% |
| 2021 Q4 | -20.71 Million USD | 0.0% |
| 2021 Q2 | 3.06 Million USD | 0.0% |
| 2021 FY | -20.71 Million USD | -493.44% |
| 2020 Q4 | 5.26 Million USD | 0.0% |
| 2020 FY | 5.26 Million USD | 74.24% |
| 2020 Q2 | 3.63 Million USD | 0.0% |
| 2019 Q4 | 2.18 Million USD | 0.0% |
| 2019 FY | 3.02 Million USD | 215.51% |
| 2018 FY | -2.61 Million USD | 86.05% |
| 2017 FY | -18.75 Million USD | -3.63% |
| 2016 FY | -18.09 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 505.81% |
| Alkermes plc | -166.73 Million USD | 236.147% |
| Agenus Inc. | 274.13 Million USD | 17.191% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 87.86% |
| Aptorum Group Limited | 1.35 Million USD | -16628.238% |
| Ardelyx, Inc. | 34.51 Million USD | -557.771% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -5203.969% |
| Bicycle Therapeutics plc | -481.46 Million USD | 147.15% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -527.741% |
| ChromaDex Corporation | -24.04 Million USD | 1043.987% |
| Chimerix, Inc. | -25.51 Million USD | 989.642% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -3157.856% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 1058.778% |
| CRISPR Therapeutics AG | -150.84 Million USD | 250.492% |
| Precision BioSciences, Inc. | -85.41 Million USD | 365.788% |
| Dyadic International, Inc. | -6.37 Million USD | 3659.209% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 1524.778% |
| Fortress Biotech, Inc. | 7.66 Million USD | -2861.642% |
| Lantern Pharma Inc. | -21.7 Million USD | 1145.971% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 305.37% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 2757.207% |
| Incyte Corporation | -3.17 Billion USD | 107.15% |
| IO Biotech, Inc. | -140.69 Million USD | 261.344% |
| Jaguar Health, Inc. | 29.39 Million USD | -672.379% |
| Novavax, Inc. | -298.29 Million USD | 176.103% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -4153.511% |
| Opthea Limited | 28.15 Million USD | -706.216% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 1452.135% |
| ContextLogic Inc. | -232 Million USD | 197.849% |
| MiMedx Group, Inc. | -33.9 Million USD | 769.626% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -2126.679% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 9897.464% |
| NextCure, Inc. | -6.47 Million USD | 3604.862% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 549.516% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 3658.707% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -1766.356% |
| Vaxcyte, Inc. | -368.22 Million USD | 161.649% |
| PDS Biotechnology Corporation | -32.7 Million USD | 794.031% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -1213.867% |
| Pharming Group N.V. | 109.8 Million USD | -106.741% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 1404.955% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 229.55% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1325.765% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1325.765% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 3297.322% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 3973.889% |
| Acelyrin, Inc. | -216.9 Million USD | 204.66% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 4146.33% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 13267.627% |
| Summit Therapeutics Inc. | 34.67 Million USD | -554.698% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 3436.909% |
| Senti Biosciences, Inc. | 1.74 Million USD | -12946.545% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 222.969% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 393.101% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 3844.802% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -227435.498% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -36048.072% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 293.949% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 234.938% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -104.753% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 3088.545% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 275.821% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -3192.576% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 193.665% |
| Immix Biopharma, Inc. | -17.5 Million USD | 1396.474% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 171.679% |
| MEI Pharma, Inc. | -3.7 Million USD | 6227.123% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -1714.482% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -40.353% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -716.788% |
| Fortress Biotech, Inc. | 7.66 Million USD | -2861.642% |
| Precigen, Inc. | -481 Thousand USD | 47295.404% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -1512.172% |
| AlloVir, Inc. | -62.69 Million USD | 462.103% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 508.188% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -268.128% |
| ImmuCell Corporation | 10.99 Million USD | -1965.498% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 247.269% |
| Onconetix, Inc. | 5.33 Million USD | -4157.949% |
| PureTech Health plc | -167.19 Million USD | 235.774% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 845.272% |
| Elevation Oncology, Inc. | -19.11 Million USD | 1287.414% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 4724.361% |
| Seer, Inc. | -4.24 Million USD | 5454.007% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 1044.419% |
| Innoviva, Inc. | 255.56 Million USD | 11.173% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 506.362% |
| ESSA Pharma Inc. | -33.62 Million USD | 775.191% |
| GlycoMimetics, Inc. | -40.98 Million USD | 653.893% |
| GT Biopharma, Inc. | -1.02 Million USD | 22334.074% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 434.907% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -270.586% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 269.311% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 1738.351% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 886.263% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 301437.897% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 835.564% |
| Aptose Biosciences Inc. | -8.19 Million USD | 2870.151% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 7354.988% |
| Soligenix, Inc. | -4.95 Million USD | 4684.579% |
| Century Therapeutics, Inc. | 847 Thousand USD | -26701.64% |
| Kura Oncology, Inc. | -20.11 Million USD | 1228.392% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 654.684% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 2803.142% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -12361.465% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 7200.716% |
| Autolus Therapeutics plc | -186.59 Million USD | 221.657% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 560.429% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 182.311% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -562.454% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -38.111% |
| GRI Bio, Inc. | -1.79 Million USD | 12753.84% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 2627.093% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 782.593% |
| IGM Biosciences, Inc. | -72.6 Million USD | 412.66% |
| INmune Bio, Inc. | -25.41 Million USD | 993.353% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -50.386% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 548.114% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 1497.038% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 7968.829% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -497.159% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 651.196% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -611.965% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 39.937% |
| Verastem, Inc. | -37.27 Million USD | 708.965% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 2602.038% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 537.719% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 1599.9% |
| Histogen Inc. | -7.48 Million USD | 3132.054% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 1150.64% |
| Surrozen, Inc. | -32.66 Million USD | 794.985% |
| Organovo Holdings, Inc. | -1.5 Million USD | 15163.695% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 5500.512% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -1097.296% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -8577.748% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -5362.221% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 2808.577% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 622.559% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 1657.331% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 171.66% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 31539.2% |
| Apollomics, Inc. | -27.39 Million USD | 928.654% |
| Amarin Corporation plc | -191.04 Million USD | 218.828% |
| Mesoblast Limited | 55.96 Million USD | -305.643% |
| Turnstone Biologics Corp. | -14.58 Million USD | 1656.568% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 997.556% |
| Synaptogenix, Inc. | -28.66 Million USD | 892.038% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 24353.193% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -365.833% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 26432.535% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 3224.242% |
| Exelixis, Inc. | -73.05 Million USD | 410.76% |
| Better Therapeutics, Inc. | -860 Thousand USD | 26496.499% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 1045.362% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 194.05% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -30740.97% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 3151.973% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -18002.862% |
| Gritstone bio, Inc. | 39.49 Million USD | -474.854% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 369.925% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 8724.537% |
| Avid Bioservices, Inc. | 169.72 Million USD | -33.749% |
| Insmed Incorporated | 721.62 Million USD | 68.542% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 2583.286% |
| MediWound Ltd. | -5.32 Million USD | 4365.5% |
| OmniAb, Inc. | 9.2 Million USD | -2366.694% |
| Alector, Inc. | -35.63 Million USD | 737.006% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -164.054% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 4706.532% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -1614.706% |
| Zai Lab Limited | -775 Million USD | 129.292% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 33.341% |
| Aura Biosciences, Inc. | -21.52 Million USD | 1154.634% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 375.23% |
| Immunic, Inc. | -45.34 Million USD | 600.683% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 217.491% |
| Veracyte, Inc. | -203.82 Million USD | 211.375% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 64.435% |
| FibroGen, Inc. | 56.76 Million USD | -299.898% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -2449.241% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 8129.83% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 11064.818% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 95.055% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 6894.669% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 236.783% |
| TG Therapeutics, Inc. | 17.86 Million USD | -1170.91% |
| Galecto, Inc. | -21.21 Million USD | 1169.994% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 1054.425% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 85.535% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 1027.631% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 2072.798% |
| XBiotech Inc. | -200.02 Million USD | 213.492% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 369.925% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -4913.469% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 743.762% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 393.986% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -3888.928% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 233.21% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 345.751% |
| Vaxxinity, Inc. | 10.13 Million USD | -2140.524% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 69.167% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 2208.278% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 444.184% |
| NexImmune, Inc. | -3.13 Million USD | 7344.281% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 6674.903% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 1602.238% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 937.675% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 2629.061% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 182327.486% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 659.524% |
| Ainos, Inc. | 4.07 Million USD | -5466.795% |
| Pluri Inc. | 22.82 Million USD | -894.393% |
| Prothena Corporation plc | -608.34 Million USD | 137.316% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 291.157% |
| Celularity Inc. | 65.19 Million USD | -248.228% |
| Rallybio Corporation | -24.1 Million USD | 1041.872% |
| Cue Biopharma, Inc. | -33.81 Million USD | 771.25% |
| MeiraGTx Holdings plc | -40.3 Million USD | 663.272% |
| Omeros Corporation | 331.17 Million USD | 31.453% |
| Humacyte, Inc. | -22.48 Million USD | 1109.561% |
| Immunocore Holdings plc | -358.59 Million USD | 163.306% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 1023.743% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 834.636% |
| Blueprint Medicines Corporation | 702.83 Million USD | 67.701% |
| CalciMedica, Inc. | -5.53 Million USD | 4205.061% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 220.609% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 2322.537% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 667.0% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 782.675% |
| Pulmatrix, Inc. | -10.41 Million USD | 2279.225% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 3898.057% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 695.17% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 303.775% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 478.703% |
| Cytokinetics, Incorporated | 642.37 Million USD | 64.661% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 3998.504% |
| Nutriband Inc. | -251.65 Thousand USD | 90306.071% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 765.347% |
| Vor Biopharma Inc. | 4.3 Million USD | -5179.3% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 103.761% |
| Evogene Ltd. | -19.63 Million USD | 1256.208% |
| ProKidney Corp. | -56.23 Million USD | 503.674% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 566.408% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 2557.565% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 83.356% |
| CorMedix Inc. | -43.05 Million USD | 627.286% |
| BioLineRx Ltd. | 7.33 Million USD | -2994.464% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 926.542% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -391.928% |
| Atai Life Sciences N.V. | -28.55 Million USD | 894.908% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -10077.401% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 1094.959% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -1180.011% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 402.382% |
| MediciNova, Inc. | -50.78 Million USD | 547.015% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 388.065% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1009257.106% |
| GeoVax Labs, Inc. | -6.45 Million USD | 3618.121% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 213.607% |
| Biomea Fusion, Inc. | -166.57 Million USD | 236.285% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 226.839% |
| Mereo BioPharma Group plc | -51.46 Million USD | 541.061% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 339.351% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 177.278% |
| Absci Corporation | -72.59 Million USD | 412.694% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -4871.745% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 196.832% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 340.959% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 337.22% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 680.989% |
| Allakos Inc. | -24.97 Million USD | 1008.949% |
| Imunon, Inc. | -4.21 Million USD | 5487.23% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 1639.885% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 267.659% |
| BioAtla, Inc. | -109.01 Million USD | 308.245% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -30740.97% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 24275.707% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -1797.124% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 1170.65% |
| XOMA Corporation | -29 Million USD | 882.793% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 1470.833% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 2617.856% |
| aTyr Pharma, Inc. | -7.44 Million USD | 3147.522% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 282.138% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 209.053% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 377.589% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 344.72% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 26521.569% |
| Akari Therapeutics, Plc | -3.84 Million USD | 6004.028% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -13888.002% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 83.56% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 19206.406% |
| UroGen Pharma Ltd. | 4.39 Million USD | -5069.89% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -100.042% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -315358.007% |
| Orgenesis Inc. | 21.78 Million USD | -942.095% |
| Entera Bio Ltd. | -10.62 Million USD | 2235.76% |
| GH Research PLC | -78.07 Million USD | 390.751% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 1118.53% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 951.532% |
| Xencor, Inc. | 29.64 Million USD | -665.787% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 11624.445% |
| Replimune Group, Inc. | 1.41 Million USD | -15977.188% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 92791.905% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 279.572% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 19206.406% |
| Portage Biotech Inc. | -4.98 Million USD | 4657.516% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1009257.106% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 443.32% |
| OncoCyte Corporation | -6.56 Million USD | 3558.935% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -25196.033% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 5083.048% |
| Purple Biotech Ltd. | -14.13 Million USD | 1705.672% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 1055.59% |
| scPharmaceuticals Inc. | -6.54 Million USD | 3568.448% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 1459.979% |
| HilleVax, Inc. | -165.48 Million USD | 237.179% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 9044.44% |
| Tharimmune, Inc. | -10.93 Million USD | 2175.927% |
| Genprex, Inc. | -6.73 Million USD | 3469.285% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 161.552% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 356.624% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 16303.418% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 6943.943% |
| OKYO Pharma Limited | -826.84 Thousand USD | 27554.852% |
| Savara Inc. | 153 Thousand USD | -148272.478% |
| Curis, Inc. | -23.88 Million USD | 1050.349% |
| Daré Bioscience, Inc. | -5.15 Million USD | 4501.198% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 29353.4% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 3756.731% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -19056.953% |
| BeiGene, Ltd. | -2.25 Billion USD | 110.076% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -1739.85% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 137.325% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 222.321% |
| Erasca, Inc. | -37.21 Million USD | 709.979% |
| bluebird bio, Inc. | 108.57 Million USD | -109.089% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 17726.456% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 40.063% |
| DBV Technologies S.A. | -126.98 Million USD | 278.768% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 17726.456% |
| Moderna, Inc. | -2.9 Billion USD | 107.809% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 2292.909% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 2188.792% |
| Molecular Templates, Inc. | 707 Thousand USD | -32008.895% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 823.63% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 34.505% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 376.632% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 347.476% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 803.427% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 760.373% |
| MacroGenics, Inc. | -66.98 Million USD | 438.897% |
| RenovoRx, Inc. | -1.17 Million USD | 19452.932% |
| Adicet Bio, Inc. | -138.78 Million USD | 263.567% |
| Prime Medicine, Inc. | -27.94 Million USD | 912.462% |
| Aditxt, Inc. | 18.12 Million USD | -1152.753% |
| Adagene Inc. | -87.62 Million USD | 359.063% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 5549.858% |
| Quantum-Si incorporated | -118.55 Million USD | 291.477% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -530.495% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 3137.252% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 567.975% |
| SciSparc Ltd. | -2.06 Million USD | 11093.215% |
| Vericel Corporation | 1.27 Million USD | -17676.812% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 1993.058% |
| Minerva Neurosciences, Inc. | 41 Million USD | -453.625% |
| Generation Bio Co. | 31.44 Million USD | -621.858% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 229.451% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 834.113% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -94.703% |
| Invivyd, Inc. | -198.47 Million USD | 214.376% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 351.479% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 9567.865% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 420.681% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 3426.152% |
| 2seventy bio, Inc. | 181.71 Million USD | -24.926% |
| ADMA Biologics, Inc. | 90.06 Million USD | -152.048% |
| Clene Inc. | 3.34 Million USD | -6696.703% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 2599.365% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 1155.32% |
| GeoVax Labs, Inc. | -6.45 Million USD | 3618.121% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 165.967% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 973.126% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -27.773% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 5648.238% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -4438.382% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 4458.032% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 274.216% |
| Evaxion Biotech A/S | 5.28 Million USD | -4193.864% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 301.665% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 272.93% |
| Trevena, Inc. | 2.25 Million USD | -9953.582% |
| Surrozen, Inc. | -32.66 Million USD | 794.985% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 540.71% |
| Cingulate Inc. | 3.08 Million USD | -7264.036% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 7829.312% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -3058.618% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 2543.271% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 386.184% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 272.694% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 315.09% |
| Clearmind Medicine Inc. | -3.94 Million USD | 5857.819% |
| Kronos Bio, Inc. | -36.05 Million USD | 729.639% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -2312.689% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -15468.595% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 518.405% |
| Statera Biopharma, Inc. | 14.41 Million USD | -1474.664% |
| ImmunityBio, Inc. | 618.22 Million USD | 63.28% |
| Korro Bio, Inc. | -132.94 Million USD | 270.757% |
| Kineta, Inc. | -4.54 Million USD | 5099.117% |
| BioVie Inc. | -17.73 Million USD | 1380.202% |
| Codexis, Inc. | -43.27 Million USD | 624.624% |
| Celularity Inc. | 65.19 Million USD | -248.228% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 7263.455% |
| Celcuity Inc. | 6.78 Million USD | -3246.496% |
| Virax Biolabs Group Limited | -3.36 Million USD | 6846.32% |
| Cibus, Inc. | -8.07 Million USD | 2910.224% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 5467.933% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -4867.394% |
| IN8bio, Inc. | -16.38 Million USD | 1485.136% |
| Kodiak Sciences Inc. | -103.87 Million USD | 318.541% |
| Annexon, Inc. | -193.75 Million USD | 217.163% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -630483.031% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 1397.274% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 6561.995% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 78.468% |
| Eyenovia, Inc. | 1.25 Million USD | -17935.237% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -743.746% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 7099.997% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 782.798% |
| Arcellx, Inc. | -296.95 Million USD | 176.445% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 1263.795% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 485.579% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 1195.238% |
| Moolec Science SA | 117.61 Thousand USD | -192909.362% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 691.187% |
| Geron Corporation | 14.76 Million USD | -1437.903% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 698.686% |
| Royalty Pharma plc | 5.65 Billion USD | 95.988% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 260.521% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 3347.906% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 4333.001% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 261.308% |
| Humacyte, Inc. | -22.48 Million USD | 1109.561% |
| Structure Therapeutics Inc. | -124.33 Million USD | 282.573% |
| 89bio, Inc. | -289.05 Million USD | 178.536% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 999.334% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 12831.906% |
| Genelux Corporation | -6.89 Million USD | 3390.475% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 830.899% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -171.546% |
| Notable Labs, Ltd. | -9.77 Million USD | 2422.114% |
| Liquidia Corporation | -80.17 Million USD | 383.139% |
| Mustang Bio, Inc. | -3.73 Million USD | 6176.282% |
| Immunovant, Inc. | -635.22 Million USD | 135.737% |
| Quantum-Si incorporated | -118.55 Million USD | 291.477% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 1392.473% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 5579.36% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -2728.079% |
| Acasti Pharma Inc. | -23 Million USD | 1086.785% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 6841.742% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 1497.038% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 264.81% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 7384.452% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 1121.095% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 1322.521% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 234.105% |
| PepGen Inc. | -60.67 Million USD | 474.172% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 1088.031% |
| United Therapeutics Corporation | -507.7 Million USD | 144.713% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 1286.918% |
| Solid Biosciences Inc. | -47.75 Million USD | 575.413% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 26432.535% |
| Immuneering Corporation | -54.94 Million USD | 513.175% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 5500.512% |
| Silo Pharma, Inc. | -3.52 Million USD | 6541.261% |
| Belite Bio, Inc | -87.27 Million USD | 360.121% |
| XOMA Corporation | -29 Million USD | 882.793% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 421.103% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 295.224% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 9062.096% |
| uniQure N.V. | -102.95 Million USD | 320.503% |
| Cassava Sciences, Inc. | -121.13 Million USD | 287.401% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 5549.858% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -454.345% |
| Forte Biosciences, Inc. | -11.96 Million USD | 1997.917% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 7436.626% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -214060.275% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 7099.997% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -2449.241% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 3161.083% |
| Altimmune, Inc. | -134.48 Million USD | 268.797% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -14.614% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 9062.096% |
| Compugen Ltd. | -12.9 Million USD | 1859.221% |
| Peak Bio, Inc. | 10.34 Million USD | -2095.42% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 80315.509% |
| Benitec Biopharma Inc. | -50.58 Million USD | 548.796% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 317.572% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -1055.561% |
| Zura Bio Limited | -99.8 Million USD | 327.451% |
| PolyPid Ltd. | 6.17 Million USD | -3579.253% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -206.273% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -1055.561% |
| Instil Bio, Inc. | 75.35 Million USD | -201.242% |
| argenx SE | -2.02 Billion USD | 111.189% |
| Immunome, Inc. | -97.02 Million USD | 333.961% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 1109.157% |
| Verona Pharma plc | -220.44 Million USD | 202.979% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 416.421% |
| Shattuck Labs, Inc. | -121.42 Million USD | 286.956% |
| CervoMed Inc. | -7.79 Million USD | 3013.055% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 222.378% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 5291.171% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 272.317% |
| Moolec Science SA | 117.61 Thousand USD | -192909.362% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 10021.861% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -1327.881% |
| AnaptysBio, Inc. | -18.15 Million USD | 1350.674% |
| Design Therapeutics, Inc. | -18.15 Million USD | 1350.743% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 422.544% |
| NeurAxis, Inc. | 145.7 Thousand USD | -155706.377% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -1921.099% |
| Lumos Pharma, Inc. | -28.49 Million USD | 896.722% |
| Achilles Therapeutics plc | -126.92 Million USD | 278.855% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 416.421% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 34719.415% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 1192.769% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -15468.595% |
| Nutriband Inc. | -251.65 Thousand USD | 90306.071% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 1823.559% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 3151.208% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 33.271% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -856.435% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 150.732% |
| Palisade Bio, Inc. | -12.06 Million USD | 1981.869% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 261.791% |
| Beam Therapeutics Inc. | -262.72 Million USD | 186.407% |
| Neurogene Inc. | -131.95 Million USD | 272.036% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -940.566% |
| AEON Biopharma, Inc. | -4.88 Million USD | 4751.842% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 160.184% |
| Sesen Bio, Inc. | -112.55 Million USD | 301.692% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 327.328% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 9769.076% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 681.689% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 372.58% |
| Athira Pharma, Inc. | -88.99 Million USD | 355.07% |
| Vaccinex, Inc. | -1.28 Million USD | 17724.992% |
| HCW Biologics Inc. | 2.85 Million USD | -7846.645% |
| XOMA Corporation | -29 Million USD | 882.793% |
| Nektar Therapeutics | 210.24 Million USD | -7.977% |
| Arvinas, Inc. | -313.8 Million USD | 172.342% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -13888.002% |
| Merus N.V. | -192.88 Million USD | 217.692% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -278.444% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 3371.979% |
| Rezolute, Inc. | -68.16 Million USD | 433.015% |
| Clene Inc. | 3.34 Million USD | -6696.703% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 1821.467% |
| BeyondSpring Inc. | -13.75 Million USD | 1750.381% |
| Synlogic, Inc. | -6.68 Million USD | 3495.81% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -19918.509% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 2784.919% |
| Peak Bio, Inc. | 10.34 Million USD | -2095.42% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 375.431% |
| Krystal Biotech, Inc. | -350.23 Million USD | 164.817% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -82.888% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 234.329% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 7290.356% |
| MannKind Corporation | 143.89 Million USD | -57.756% |
| Ikena Oncology, Inc. | -109.15 Million USD | 307.968% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 3098.414% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 785.83% |
| Gossamer Bio, Inc. | 180.35 Million USD | -25.868% |
| CohBar, Inc. | -5.93 Million USD | 3927.688% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 863.11% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -4871.745% |
| Legend Biotech Corporation | -949.39 Million USD | 123.911% |
| Mural Oncology plc | -255.84 Million USD | 188.73% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -604.671% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 4919.086% |
| Disc Medicine, Inc. | -358.28 Million USD | 163.361% |
| Champions Oncology, Inc. | 4.81 Million USD | -4617.579% |
| REGENXBIO Inc. | 54.76 Million USD | -314.494% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 84519.48% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 250.314% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 2618.972% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 381.36% |
| Vaxart, Inc. | -8.24 Million USD | 2854.64% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 552.391% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 278.515% |
| Cellectis S.A. | -43.85 Million USD | 617.637% |
| Longeveron Inc. | -2.9 Million USD | 7906.392% |
| Repare Therapeutics Inc. | -107.85 Million USD | 310.471% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 76.558% |
| Inozyme Pharma, Inc. | 12 Million USD | -1791.119% |
| Revolution Medicines, Inc. | -608.2 Million USD | 137.325% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 18556.089% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 185.626% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 251.267% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 1550.821% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 30777.012% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 102.374% |
| Denali Therapeutics Inc. | -74.86 Million USD | 403.226% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 1993.058% |
| Veru Inc. | 4.77 Million USD | -4649.192% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 2118.583% |
| Cingulate Inc. | 3.08 Million USD | -7264.036% |
| Passage Bio, Inc. | 4.58 Million USD | -4851.143% |
| Context Therapeutics Inc. | -14.44 Million USD | 1671.022% |
| Exicure, Inc. | 5.84 Million USD | -3781.174% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 198.539% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 673.692% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -1346.752% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 485.933% |
| Nuvalent, Inc. | -335.38 Million USD | 167.686% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -12989.115% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 404.785% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 2653.542% |
| OmniAb, Inc. | 9.2 Million USD | -2366.694% |
| Anew Medical, Inc. | 1.43 Million USD | -15747.5% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -1285.748% |
| Lipocine Inc. | -4.75 Million USD | 4874.54% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 306.696% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -1390.446% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 548.114% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -811.979% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 3477.621% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 444.858% |
| Ocugen, Inc. | -32.52 Million USD | 798.041% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 365.276% |
| Q32 Bio Inc. | -37.94 Million USD | 698.213% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 36248.072% |
| Alumis Inc. Common Stock | -13.52 Million USD | 1777.95% |
| Equillium, Inc. | -22.39 Million USD | 1113.799% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 987.867% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 795.778% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 91667.63% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -69.357% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -6998.496% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -69017.403% |
| Dominari Holdings Inc. | 195 Thousand USD | -116315.329% |
| Edesa Biotech, Inc. | -5.26 Million USD | 4410.115% |
| vTv Therapeutics Inc. | -8.91 Million USD | 2645.81% |
| Bio-Techne Corporation | 267.74 Million USD | 15.215% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 1500.518% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 292.228% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 2801.534% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 1894.403% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 192.612% |
| Nkarta, Inc. | 57.29 Million USD | -296.185% |
| BioCardia, Inc. | 212 Thousand USD | -106980.137% |
| Iterum Therapeutics plc | 13.43 Million USD | -1589.313% |